Entrustable Professional Activity

Similar documents
Entrustable Professional Activity

Entrustable Professional Activity

2. Description of the activity

Entrustable Professional Activity

Overall Goals and Objectives for Transplant Hepatology EPAs:

Curricular Components for Rheumatology EPA

Curricular Components for Cardiology EPA

List of NASPGHAN EPAs

LIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.

GASTROENTEROLOGY Maintenance of Certification (MOC) Examination Blueprint

M3 Pediatric Clerkship

Liver failure &portal hypertension

Gastroenterology. Certification Examination Blueprint. Purpose of the exam

DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL

Index. Note: Page numbers of article titles are in boldface type.

Curricular Components for Hematology/Oncology EPA

Evaluating HIV Patient for Liver Transplantation. Marion G. Peters, MD Professor of Medicine University of California San Francisco USA

1. Discuss the basic pathophysiology of end-stage liver and kidney failure.

Transplant Hepatology

Curricular Components for Infectious Diseases EPA

Chronic Hepatic Disease

The Continuum of Care for Advanced Liver Disease: Partnering with the Liver Specialist. K V Speeg, MD, PhD UT Health San Antonio

PALLIATIVE CARE IN END-STAGE LIVER DISEASE

WEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry

End Stage Liver Disease & Disease Specific Indications for Liver Transplant. Susan Kang, RN, MSN, ANP-BC

End Stage Liver Disease & Disease Specific Indications for Liver Transplant Susan Kang, RN, MSN, ANP BC

During the course of the 12 month fellowship, candidates will attend at least one international liver meeting (generally AASLD).

Int. J. Pharm. Sci. Rev. Res., 46(1), September - October 2017; Article No. 07, Pages: 37-41

Gastroenterology Fellowship Program

Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide

Liver Transplantation Evaluation: Objectives

Lahey Clinic Internal Medicine Residency Program: Curriculum for Gastroenterology

Treating patients with end-stage liver disease: Are we ready? Dr. Mino R. Mitri, M.D., C.M., M.Ed., FRCPC

Curriculum: Goals and Objectives Department of Medicine Harbor-UCLA Medical Center

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

Hepatitis Panel/Acute Hepatitis Panel

following the last documented transfusion; thereafter, evaluate the residual impairment(s).

Evaluation Process for Liver Transplant Candidates

The Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust

Liver Failure. The most severe clinical consequence of liver disease is liver failure:

CLINICAL How Should a Hospitalized Patient with Newly Diagnosed Cirrhosis Be Evaluated and Managed?

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology

Curricular Components for General Pediatrics EPA EPA Title Assess and manage patients with common behavior/mental health problems

Initial Evaluation for HCV Therapy. Hope McGratty PA-C, MPH

Cedars Sinai Medical Center Pediatric Electives

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease

Nephrology. 2. To facilitate a trainee to acquire the knowledge, clinical skills, procedural competence and professional attributes in Nephrology.

Curricular Components for Child Sexual Abuse EPA

CrackCast Episode 28 Jaundice

Assessing the patient with a new diagnosis of Hepatitis C LAUREN MYERS MMSC, PA-C OREGON HEALTH & SCIENCE UNIVERSITY

UCSD DEPARTMENT OF ANESTHESIOLOGY

MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT

Program Directors Meeting Pediatric Endocrine Society Baltimore, MD

Hepatitis C Policy Discussion

What Is Cirrhosis? CIRRHOSIS. Cirrhosis occurs when the liver is. by chronic conditions and diseases. permanently scarred or injured

DUKE INTERNAL MEDICINE RESIDENCY PROGRAM NEUROLOGY CONSULTS ROTATION DESCRIPTION.

Steps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV

Learning Objectives. After attending this presentation, participants will be able to:

CHAPTER 7. End Stage Liver Disease in the ICU: Walking a Tightrope. Lynn A. Kelso, MSN, APRN, FCCM, FAANP University of Kentucky College of Nursing

Differentiate IgE-mediated food allergy from non-ige mediated food allergy. List the foods and formulas most commonly associated with food allergy.

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center

Primary Sclerosing Cholangitis and Cholestatic liver diseases. Ahsan M Bhatti MD, FACP Bhatti Gastroenterology Consultants

Alpha-1 Antitrypsin Deficiency: Liver Disease

Liver Transplantation: The End of the Road in Chronic Hepatitis C Infection

Lemuel Shattuck Hospital Consultation Service

Child Neurology Elective PL1 Rotation

Educational Goals & Objectives

IN-TRAINING ASSESSMENT REPORT (ITAR)

ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries

Overview of PSC Jayant A. Talwalkar, MD, MPH Associate Professor of Medicine Mayo Clinic Rochester, MN

Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association

Hepatitis C Virus (HCV): Current Screening Guidelines and Treatment Approaches

Hepatitis Panel/Acute Hepatitis Panel

Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL

Hepatitis B Virus. Taylor Page PharmD Candidate 2019 February 1, 2019

PROGRAMME AT A GLANCE

Validation of Clinical Outcomes in Electronic Data Sources

HOSPITAL MEDICINE BECOMING A PHYSICIAN

Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting?

Natural history of α-1-atd in children

Index. Crit Care Clin 19 (2003)

CONTROLLED DOCUMENT. Cirrhosis Care Bundle CATEGORY: Clinical Guidelines. CLASSIFICATION: Clinical. Controlled Document CG201 Number:

Noncalculous Biliary Disease Dean Abramson, M.D. Gastroenterologists, P.C. Cedar Rapids. Cholestasis

Management of Cirrhosis Related Complications

Pediatric PSC A children s tale

Liver Cancer (Hepatocellular Carcinoma or HCC) Overview

Etiology of liver cirrhosis

The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Gastroenterology

Ontario s Adult Referral and Listing Criteria for Liver Transplantation

Acute Liver Failure. Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018

Gastrointestinal System: Accessory Organ Disorders

ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology

Cirrhosis of the Liver

NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease

Cirrhosis. What is cirrhosis?

Alcohol-Related Liver Disease

The Sheila Sherlock Royal Free Hepatology Postgraduate Course Date: 15 th 17 th May 2019 Location: Royal Free Hospital, London, United Kingdom

Prognosis of untreated Primary Sclerosing Cholangitis (PSC) Erik Christensen Copenhagen, Denmark

Definition: fibrosis and nodular regeneration resulting from hepatocellular injury

Hepatitis C Virus (HCV)

Transcription:

Entrustable Professional Activity 1. EPA Title: Care of infants, children and adolescents with acute and chronic s 2. Description of Activity Practicing subspecialists must be trained to care for children and adolescents with acute and chronic. Within pediatric gastroenterology subspecialty, these relatively uncommon conditions account for a significant amount of morbidity and mortality. Pediatric gastroenterologists need to be familiar with classic understanding of processes. Additionally, subspecialists should be able to manage acute issues as well as long-term management of chronic illnesses including the transition of care. This requires a multitude of competencies within each domain of competence. The functions required of this activity include: 1. Understand the epidemiology, pathogenesis and natural history of acute and chronic 2. Understand basic/translational/clinical research in children with acute and chronic 3. Diagnose and recognize children with suspected in a variety of clinical presentations 4. Manage children and adolescents with 5. Educate parents and children on cause, treatment, and clinical course. 6. Lead and direct care for children/adolescents with in the medical system including coordinating care 3. Domains of Competence (Judicious Mapping) X Patient Care X Medical Knowledge and Diagnostic Skills Required X Practice Based Learning X Interpersonal Skills Professionalism System-based Practice X Personal and Professional Development 4. Competencies within each domain critical to entrustment decision (From Pediatric Milestones Document) PC 5, 9 MK 1, 2 PBLI 2, 8, 10 ICS 2 PPD 5, 8

5. Curriculum - List Specific Knowledge, skills and attitudes needed to execute EPA Medical Knowledge Patient Care 1. Understand differences between acute and chronic. 2. Demonstrate knowledge of the differential diagnosis for acute (eg. acute infectious hepatitis, drug/toxin hepatitis, Acute Liver Failure (ALF)) and chronic (eg. Chronic viral hepatitis, Autoimmune Hepatitis, Non-alcoholic Steatohepatitis, congenital ) including clinical presentation and features, epidemiology, natural history and treatment (including liver transplantation). 3. Understand the basic science of the acute and chronic etiologies including pathogenesis, genetics, and immunology. 4. Recognize the clinical and laboratory findings of a child in ALF and understand the management of ALF (including PICU support, prevention/treatment of complication, hepatic support and consideration for liver transplantation) 5. Understand the mechanism of action, side effects, and other complications of medications and treatments for chronic liver disease including immunosuppression medical regimens, nutritional and vitamin supplementation, and other medications. 6. Understand the extrahepatic manifestation of, including but not limited to neurological involvement, renal disease, and hematological disorders. 7. Demonstrate knowledge and be able to recognize complications of, including malnutrition and growth failure, pruritus, ascending cholangitis, portal hypertension, ascites, variceal bleeding, coagulopathy, hepatic encephalopathy, hepatorenal syndrome, hepatopulmonary syndrome, bacterial infections (spontaneous bacterial peritonitis) and hepatocellular carcinoma. 8. Recognize signs and symptoms of End Stage Liver Disease (ESLD) and timing to refer for liver transplantation. 9. Demonstrate knowledge on transmission and prevention strategies for the viral hepatitis. 1. Gather essential an accurate information of risk factors such as intravenous injections, foreign travel, contact with jaundiced individuals, medications/toxin exposures, and in adolescents if sexually active. 2. Perform an initial appropriate physical examination, with evaluation for evidence of chronic including hepatomegaly, splenomegaly, ascites, and a complete neurological exam for evaluation of encephalopathy. 3. Perform an appropriate initial workup for a child with acute and chronic (laboratory, imaging, and histological interpretation). Understand that the etiology for ALF is usually age dependent and thus need for tailoring of initial workup. 4. Establish the diagnosis, stage the disease and detect complications of. 5. Develop an initial treatment plan with monitoring of medications side effects. 6. Recognize remission and flare in chronic and develop a treatment plan for disease flares and maintenance therapy. 7. Monitoring and recognition of complications of both acute and chronic. 8. Perform endoscopy for prophylaxis and/or therapeutic treatment of esophageal varices.

9. Understand imaging modalities for including but not limited to abdominal radiography, ultrasonograpy with dopplers, CT scans and MRI, including MRCP. 10. Understand the use of treatment modalities for including: a. Steroids b. Immunomodulators c. Biologics d. Anti-virals e. Oral, enteral and parenteral nutrition f. Other medications (vit E, vit D, vit K, fish oil, etc) g. Pharmacotherapy in portal hypertension, eg. Beta-blockers, octreotide h. Endocospic or surgical treatment for portal hypertension i. Aldosterone antagonist and diuretics for ascites j. Albumin infusion k. Pharmacotherapy for hepatic encephalopathy (lactulose, antibiotics) l. Non-conventional therapies:, alternative medicine m. Liver transplantation n. Evolving Therapies / New Treatment Modalities- hepatic support (eg. Molecular Absorbent Recirculating Systems, Hepatocyte transplantation) 11. Recognize extra-intestinal manifestations of 12. Interpret pathology findings. 13. Understand health care maintenance and vaccinations in children with chronic and immunosuppression medical regimens. 14. Recognize and manage psychosocial concerns Practice Based Learning 1. Apply evidence based medicine to the care of children with 2. Apply quality measures to improve care of children with 3. Educate parents and children on cause, treatment, and other aspects of including maintenance health check and cancer surveillance 4. Participate in lifelong learning as it relates to care of children with Interpersonal and Communication Skills 1. Effectively communicate disease information, treatment plan, and outcome to parents and children 2. Effectively communicate with other medical professionals involved in the care of patients with acute and chronic liver disease. Professionalism

1. Demonstrate compassion, integrity, respect and sensitivity to diversity in treating acute and chronic, a complex chronic disease 2. Protect patient privacy System-based Practice 1. Coordinate care of children with acute and chronic including PCPs, surgeons, psychologists/social workers, nutritionists, radiologists, and other medical professionals 2. Practice cost-effective medicine, for both outpatient clinic management and intensive inpatient therapy 3. Transition care in children with to adult gastroenterologists/hepatologists Personal and Professional Development 1. Thoughtfully analyze practice style, self-confidence and seek advice for management of complex patients 2. Develop bedside manner and maturity through interactions with patients and families 6. Assessment Procedure (from ACGME Assessment Toolbox see below): Direct observations Checklist Chart stimulated recall / Chart audits In-training examination

Quick Summary of EPA End-of-Training EPA Step 1 Description and Tasks Step 2 Domains of Competence and Competencies within each Domain Critical to Entrustment Decisions Step 3 Assessment Methods/Tools 1. Care of children and adolescents with acute and chronic liver disease Summary: The tasks required: Understand the pathogenesis, natural history, and basic/translational research on acute and chronic Diagnose and recognize children with suspected in a variety of clinical presentations Manage children and adolescents with Educate parents and children on liver disease cause, treatment, and clinical course. Lead and direct care for children/adolescents with in the medical system including coordinating care Patient Care (PC) 1 10 Checklist Chart stimulated recall Medical Knowledge (MK) 1-2 Practice-Based Learning & Improvement (PBLI) Interpersonal & Communication Skills (ICS) 1, 6, 9 1, 3, 4, 6 Professionalism (P) 1, 3, 5 Systems-Based Practice (SBP) 3, 4, 5 Chart audits Direct observations Standardized patient In-training examination 360 Global Rating Procedure Log Patient Survey Simulation Portfolios Personal and Professional Development (PPD)

EPA Title: Care of children and adolescents with acute and chronic s Level 1 Level 2 Level 3 Level 4 Level 5 Recognize clinical and laboratory data suspicious for Complete an essential history and examination on children with Understand differences between acute and chronic Recognize general categories of s including infectious (viral), metabolic, genetic, immunologic, oncologic, vascular, and obesity Training / Expertise Level Understand the natural history, epidemiology, pathogenesis, and extrahepatic manifestations of acute and chronic liver diseases Develop an appropriate initial diagnostic plan including laboratory evaluation, histology, imaging and other tests Develop an appropriate initial management plan based on etiology Understand medication classes/side effects (steroids, immune-modulators, diuretics) Perform basic education regarding diagnosis, treatment, disease course, etc Diagnose and treat viral etiologies of Diagnose and manage autoimmune hepatitis Recognize and diagnose drug related Manage chronic liver diseases including maintenance, flares, and escalation of therapy Identify complications of chronic (portal hypertension, ascites, hepatocellular carcinoma) Recognize extra-hepatic diseases associated with Iiver disease (hepatorenal, hepatopulmonary) Recognize ESLD and refer for liver transplantation Perform advanced education including side effects, longterm outcome, surgery, risk benefits and prevention Perform health care maintenance Recognize and treat genetic and metabolic disorders that result in Recognize and treat NAFLD Recognize and treat vascular causes of Manage complex advanced issues associated with liver disease including malnutrition, portal hypertension, ascites, coagulopathy, hepatic encephalopathy Understand and interpret disease monitoring modalities including clinical, laboratory, and imaging assessments Lead a multi-disciplinary team: nutritionist, surgeon, nurses, support staff, psychologist Understand indications for surgical treatment of portal hypertension and work with surgeons to develop a surgical plan of care Apply QI, Best Practices, and scientific evidence Transition care of liver disease from pediatric to adult practitioner Interpret histopathology from children and adolescents with Participate in scholarly activity related to liver disease Present research findings at a national meeting in oral format Participate in regional/national meetings specific to Be invited to speak at regional meetings/grand rounds on

Entrustment Level Execution with direct proactive supervision Execution with reactive supervision (on request) Supervision at distance post hoc supervision Entrustment, ready for unsupervised practice Supervision of others junior colleagues